Petro Health LLC
724 Maiden Choice Lane, Suite 304, Catonsville, MD 21228
Petro Health LLC is an outpatient facility in Catonsville, MD offering substance use treatment. Buprenorphine and Naltrexone are used for opioid use disorder. It reports accepting self-payment, Medicaid, Medicare, and private insurance.
Licenses and accreditations
- Drug Enforcement Agency (DEA)Registered with the Drug Enforcement Administration.
- SAMHSA certification for opioid treatment program (OTP)Certified by SAMHSA as an opioid treatment program.
Kinds of care
- Substance use treatment
- Treatment for alcohol and drug use.
Settings
- Outpatient
- Regular appointments while living at home.
- Regular outpatient treatment
- Weekly or less frequent appointments while living at home.
Medications for opioid use
- Buprenorphine used in Treatment
- Buprenorphine is used here.
- Naltrexone used in Treatment
- Naltrexone is used here.
- Lofexidine or Clonidine detoxification
- Lofexidine or clonidine to ease withdrawal during detox.
- Maintenance service with medically supervised withdrawal after stabilization
- Medication maintained, then tapered under medical supervision once stable.
- Prescribes buprenorphine
- Prescribes buprenorphine.
- Prescribes naltrexone
- Prescribes naltrexone.
Payment
- Accepted
- Cash or self-payment; Medicaid; Medicare; Private health insurance; A state-financed health insurance plan other than Medicaid.
Who they serve
- Ages served
- Adults, 26 to 64; Seniors, 65 and older; Young adults, 18 to 25.
- Sex
- Female; Male.
- Programs for
- Active duty military; Adult men; Adult women; Clients who have experienced trauma; Clients with HIV or AIDS; Clients with co-occurring mental and substance use disorders; Clients with co-occurring pain and substance use disorders; Seniors or older adults; Young adults.
- Languages
- Other languages (excluding Spanish).
- Other languages
- French.
More details this facility reports
- Type of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder.
- External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity; No formal relationship with prescribing entity.
- Pharmacotherapies
- Acamprosate (Campral®); Buprenorphine (extended-release, injectable); Buprenorphine with naloxone; Buprenorphine without naloxone; Clonidine; Disulfiram; Medication for mental disorders; Medications for HIV treatment; Medications for Hepatitis C treatment; Medications for pre-exposure to prophylaxis; Naltrexone (extended-release, injectable); Naltrexone (oral); Nicotine replacement; Non-nicotine smoking/tobacco cessation.
- Treatment Approaches
- Substance use disorder counseling; Telemedicine/telehealth therapy.
- Facility Operation (e.g., Private, Public)
- Private for-profit organization.
- Assessment/Pre-treatment
- Complete medical history/physical exam; Comprehensive substance use assessment; Screening for mental disorders; Screening for substance use; Screening for tobacco use.
- Testing
- Drug and alcohol oral fluid testing; Drug or alcohol urine screening; HIV testing; Metabolic syndrome monitoring; STD testing; TB screening; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV).
- Transitional Services
- Aftercare/continuing care.
- Education and Counseling Services
- HIV or AIDS education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Hepatitis education, counseling, or support; Individual counseling; Smoking/vaping/tobacco cessation counseling; Substance use disorder education.
- Facility Smoking Policy
- Smoking permitted without restriction.
- Facility Vaping Policy
- Vaping permitted without restriction.
- Ancillary Services
- Early intervention for HIV; Integrated primary care services.
Details are as the facility reported them to the public record. Call the facility to confirm services, availability, and coverage before you go. Something wrong here? Report a problem with this listing.